Daniel R Passeri insider trades
Open-market stock purchases and sales by Daniel R Passeri, CHIEF EXECUTIVE OFFICER at Cue Biopharma, Inc, from SEC Form 4 filings since Feb 2, 2010.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +165%.
Recent trades
No open-market trades in the last 12 months.